Literature DB >> 21544612

Adenoviral delivered eGFP-intron splicing system for multiple gene RNAi.

Xing Li1, Shihai Liu, Dongyang Wang, Hao Chen, Haibin Xia.   

Abstract

An eGFP-intron splicing system that allows for co-ordinated expression of up to four siRNAs from a single adenoviral vector has been developed. In this splicing structure the intron, embedded by a multiple miR30-based shRNAs, is located between two incomplete eGFP domains which require successful splicing for functionality. To prove the principle of the method, an adenoviral vector delivering four transcripts targeting survivin, XIAP, Hec1, and VEGF was developed which enabled the knockdown of target genes by 70, 70, 54 and 44%, respectively, in HeLa cells. This is the first report of multi-siRNA engineering technology in the context of adenoviral vector which would enable concomitant knockdown of tumor-related target genes. The results provide a strategy for gene function analysis and cancer gene therapy. © Springer Science+Business Media B.V. 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544612     DOI: 10.1007/s10529-011-0633-5

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  4 in total

1.  Inhibition of Telomerase Activity Using an EGFP-Intron Splicing System Encoding Multiple RNAi Sequences.

Authors:  O Sakiragaoglu; A L Munn
Journal:  Mol Biotechnol       Date:  2016-12       Impact factor: 2.695

2.  Expression and trafficking of placental microRNAs at the feto-maternal interface.

Authors:  Guojing Chang; Jean-François Mouillet; Takuya Mishima; Tianjiao Chu; Elena Sadovsky; Carolyn B Coyne; W Tony Parks; Urvashi Surti; Yoel Sadovsky
Journal:  FASEB J       Date:  2017-03-13       Impact factor: 5.191

Review 3.  shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy.

Authors:  Jie Zhang; Meng Ding; Kai Xu; Lijun Mao; Junian Zheng
Journal:  Oncotarget       Date:  2016-05-17

4.  Determinants of effective lentivirus-driven microRNA expression in vivo.

Authors:  Takuya Mishima; Elena Sadovsky; Margaret E Gegick; Yoel Sadovsky
Journal:  Sci Rep       Date:  2016-09-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.